Higuchi S, Urabe H, Shiobara Y
J Chromatogr. 1979 Sep 11;164(1):55-61. doi: 10.1016/s0378-4347(00)81571-6.
Lorazepam and oxazepam in plasma and urine were measured by gas chromatography-mass spectrometry. Oxazepam was used as an internal standard in the assay of lorazepam and vice versa. After removal of interfering substances with n-hexane, the drugs were extracted with benzene and converted to N1,O3-bistrimethylsilyl derivatives. Glucuronide forms of the drugs were extracted after hydrolysis with beta-glucuronidase. A common fragment ion at m/e 429 was used to monitor the two drugs. The sensitivity was 2 ng/ml for both drugs, which was sufficient to determine plasma and urine concentrations after therapeutic doses to humans.
采用气相色谱-质谱联用仪测定血浆和尿液中的劳拉西泮和奥沙西泮。在测定劳拉西泮时,奥沙西泮用作内标,反之亦然。用正己烷去除干扰物质后,用苯萃取药物并转化为N1,O3-双三甲基硅烷基衍生物。药物的葡萄糖醛酸苷形式在用β-葡萄糖醛酸酶水解后进行萃取。使用质荷比为429的共同碎片离子监测这两种药物。两种药物的灵敏度均为2 ng/ml,这足以测定给予人类治疗剂量后的血浆和尿液浓度。